Amneal Pharmaceuticals (AMRX) FCF Payout Ratio (2017 - 2018)
Amneal Pharmaceuticals (AMRX) posted FCF Payout Ratio of 0.0 for Q4 2018, up 100.0% on a QoQ basis from 1.32 in Q2 2018, and up 100.0% year-over-year from 0.0 in Q4 2017.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) FCF Payout Ratio (2017 - 2018) Analysis & Trends
Amneal Pharmaceuticals has reported FCF Payout Ratio for 2 years, with the latest figure at 0.0 in Q4 2018.
- On a quarterly basis, FCF Payout Ratio rose 100.0% year-over-year to 0.0 in Q4 2018; TTM through Sep 2019 was 0.0, a 100.0% increase from a year earlier, with the FY2018 full-year figure at 1.09, down 59.32% from the prior year.
- FCF Payout Ratio was 0.0 for Q4 2018 at Amneal Pharmaceuticals, up from 1.32 in the prior quarter.
- The five-year high for FCF Payout Ratio was 3.98 in Q1 2018, with the low at 1.32 in Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 0.42 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 0.00 |
| Jun 30, 2018 | -1.32 |
| Mar 31, 2018 | 3.98 |
| Dec 31, 2017 | -0.81 |
| Sep 30, 2017 | 1.03 |